ContactDownloadNewsPublications ITALIANO | ENGLISH | 中国 Youtube
+41 91 993 13 01 - +39 02 8715 90 82
T +41 91 993 13 01 info@seri-lugano.ch
ITALIANO中国ENGLISH
Navigation
Diabetic retinopathy
Diabetic retinopathy

What is diabetic retinopathy?
Diabetic retinopathy is a retinal condition that derives from the complications faced by sufferers of diabetes mellitus. Other causes include prolonged use of cholesterol-lowering statins.

How is diabetic retinopathy detected?
Preventive screening and early diagnostic tests are particularly effective in the timely diagnosis of diabetic retinopathy. The disease is caused by diabetes-induced damage to retinal blood vessels (microangiopathy, or small vessel disease), which in turn leads to insufficient blood and oxygen supply to some areas of the retina.

How can it be treated effectively? 
Treatment options for diabetic retinopathy include:
- laser retinal photocoagulation;
- intravitreal injections of specific drugs (such as Aflibercept) which can stimulate the proliferation of new arteries and veins and favour a healthy growth of blood vessels;
- vitrectomy.

Under the scientific guidance of its founder Dr Roberto Pinelli, the Switzerland Eye Research Institute of Lugano offers treatment and care services fordiabetic retinopathy.

More info

What is diabetic retinopathy?
Diabetic retinopathy is a retinal condition that derives from the complications faced by sufferers of diabetes mellitus. Other causes include prolonged use of cholesterol-lowering statins.

How is diabetic retinopathy detected?
Preventive screening and early diagnostic tests are particularly effective in the timely diagnosis of diabetic retinopathy. The disease is caused by diabetes-induced damage to retinal blood vessels (microangiopathy, or small vessel disease), which in turn leads to insufficient blood and oxygen supply to some areas of the retina.

How can it be treated effectively? 
Treatment options for diabetic retinopathy include:
- laser retinal photocoagulation;
- intravitreal injections of specific drugs (such as Aflibercept) which can stimulate the proliferation of new arteries and veins and favour a healthy growth of blood vessels;
- vitrectomy.

Under the scientific guidance of its founder Dr Roberto Pinelli, the Switzerland Eye Research Institute of Lugano offers treatment and care services fordiabetic retinopathy.

More info

Pinelli presby profile®

The solution for presbyopia

Cross-linking

The last frontier in the fight against Keratoconus

Refractive lensectomy

Groundbreaking innovation

FemtolasiK Lux®

The most exciting procedure in refractive surgery.

Retina & macula

Professionalism, experience
and best solutions